Human MOTS-c peptide findings
Blood concentration, muscle expression and a response to exercise describe different things. The differences are the interesting part.
A dialysis cohort
The 2024 multicenter study of chronic hemodialysis patients followed 94 people, with a median follow-up of 26.5 months. Circulating MOTS-c was independently associated with a combined endpoint of death from any cause and non-fatal cardiovascular events. The investigators studied the peptide as a possible contributor to risk prediction.
After the dialysis paper, I distrust the habit of treating a blood concentration as a health score. The authors were asking whether a measurement helped distinguish risk within a very specific population. Nobody was assigned MOTS-c treatment. A risk association in people receiving dialysis leaves the effect of adding the peptide unanswered.
Aging muscle
In healthy aging men, muscle MOTS-c expression was higher and related to muscle-fiber composition. A simple decline was the aging story I expected. The muscle finding is a useful obstacle to that expectation.
A tissue measurement has a location. Muscle expression and a serum concentration come from different specimens, and this study also drew attention to the kinds of fibers in the sample. It makes more sense to ask what a particular measurement captured than to rank everyone along a single MOTS-c scale.
Exercise responses in breast cancer survivors
The exercise intervention in 49 breast cancer survivors lasted 16 weeks and combined aerobic and resistance exercise. Plasma MOTS-c rose significantly in the non-Hispanic White participants; the Hispanic participants had no significant rise. The intervention was exercise, with the peptide measured as a response.
That group difference deserves more attention than a slogan about exercise raising MOTS-c. I hesitate to expand a small study into a rule about ancestry, too. Its particular participants and intervention set the reach of the result.
Strength and other biomarker observations
A preliminary study connected serum MOTS-c with lower-body strength while finding no relationship with maximal oxygen uptake. Another small comparison of people with multiple sclerosis and healthy controls found different serum levels between the groups.
These are useful questions about the peptide the body makes. I trust these results most when the population and specimen stay in sight, making further investigation possible. The exercise page puts the human observations alongside the animal interventions without asking either to stand in for the other.